Market Closed - Xetra 11:35:21 2024-04-18 am EDT 5-day change 1st Jan Change
40.05 EUR +2.82% Intraday chart for Stratec SE +2.30% -12.07%
Sales 2024 * 276M 293M Sales 2025 * 297M 316M Capitalization 487M 517M
Net income 2024 * 20M 21.25M Net income 2025 * 26M 27.63M EV / Sales 2024 * 2.17 x
Net Debt 2024 * 112M 119M Net Debt 2025 * 67.86M 72.11M EV / Sales 2025 * 1.87 x
P/E ratio 2024 *
23.9 x
P/E ratio 2025 *
18.5 x
Employees 1,480
Yield 2024 *
2.17%
Yield 2025 *
2.42%
Free-Float 59.43%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.82%
1 week+2.30%
Current month-0.37%
1 month-5.76%
3 months-1.11%
6 months+3.22%
Current year-12.07%
More quotes
1 week
38.10
Extreme 38.1
40.10
1 month
36.25
Extreme 36.25
43.55
Current year
36.25
Extreme 36.25
46.00
1 year
36.00
Extreme 36
69.00
3 years
36.00
Extreme 36
147.40
5 years
36.00
Extreme 36
147.40
10 years
32.10
Extreme 32.1
147.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 98-02-28
Director of Finance/CFO 56 98-04-30
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 57 19-05-28
Chairman 66 22-05-19
Director/Board Member 70 20-07-20
More insiders
Date Price Change Volume
24-04-18 40.05 +2.82% 10,946
24-04-17 38.95 -1.14% 6,990
24-04-16 39.4 +0.77% 10,013
24-04-15 39.1 +0.26% 11,511
24-04-12 39 -0.38% 6,413

Delayed Quote Xetra, April 18, 2024 at 11:35 am EDT

More quotes
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
40.05 EUR
Average target price
43.67 EUR
Spread / Average Target
+9.03%
Consensus

Quarterly revenue - Rate of surprise